HDFC MF and ADIA Lead ₹777 Crore Block Deal in Corona Remedies

A significant shift in the ownership structure of Corona Remedies Limited took place as major institutional players moved to acquire a substantial stake in the pharmaceutical company. Through a massive block deal, marquee global and domestic investors have stepped in to absorb shares offloaded by existing high-profile holders.

Major Divestments by Sepia Investments and Anchor Partners

On June 17, 2026, the stock exchange witnessed a high-value liquidity event involving Corona Remedies. The primary seller, Sepia Investments, offloaded a massive block of 43,28,943 shares. These shares were transacted at a price of ₹1,730 per share, amounting to a deal value of approximately ₹748.9 crore.

In addition to Sepia, another seller, Anchor Partners, participated in the divestment by selling 1,61,861 shares at the same price point of ₹1,730. This secondary sale contributed an additional ₹28 crore to the total transaction. Collectively, the two sellers divested shares worth roughly ₹776.9 crore, marking one of the most significant block deals in the pharmaceutical sector for the period.

HDFC Mutual Fund Dominates the Buy Side

The exit of Sepia and Anchor Partners was met with aggressive buying interest from a diverse group of twelve institutional investors. HDFC Mutual Fund emerged as the most dominant participant in this transaction, acquiring 24,50,000 shares. This single purchase, valued at approximately ₹423.9 crore, accounted for more than half of the total deal value, signaling strong domestic confidence in the company's prospects.

Other significant domestic players included Aditya Birla Sun Life Mutual Fund, which picked up 4,90,000 shares worth ₹84.8 crore, and Kotak Mahindra Mutual Fund, which acquired 1,61,861 shares worth ₹28 crore—matching the exact volume sold by Anchor Partners.

Global Institutions and Foreign Portfolio Interest

The deal also saw heavy participation from international funds, highlighting the global interest in Corona Remedies. Aberdeen Asset Management entities were prominent, with Aberdeen Asian Smaller Companies Investment Trust Plc purchasing 4,50,868 shares worth roughly ₹78 crore. Additionally, the Aberdeen Standard Sicav I - Asian Smaller Companies Fund added 2,74,132 shares (₹47.4 crore) to its portfolio.

全球重量级机构阿布扎比投资局 (ADIA) 也参与其中，购入了 39,130 股，价值约 6800 万卢比。其他国际参与者包括 Invesco Mutual Fund (5 亿卢比)、WhiteOak Capital Mutual Fund (2.51 亿卢比) 以及 TCW White Oak Emerging Markets Equity Fund；尽管后者仅购入 1,920 股，是规模最小的买家，但也为整体机构动能做出了贡献。

核心要点